Scientific Understanding of COVID-19: The First Step to Vanquishing the Current Pandemic

참고문헌

1. Carvalho, T., Krammer, F., and Iwasaki, A. (2021). The first 12 months of COVID-19: a timeline of immunological insights. Nat. Rev. Immunol. 21, 245-256. https://doi.org/10.1038/s41577-021-00522-1
2. Excler, J.L., Saville, M., Berkley, S., and Kim, J.H. (2021). Vaccine development for emerging infectious diseases. Nat. Med. 27, 591-600. https://doi.org/10.1038/s41591-021-01301-0
3. Jung, M.K. and Shin, E.C. (2021). Phenotypes and functions of SARS-CoV-2-reactive T cells. Mol. Cells 44, 401-407. https://doi.org/10.14348/molcells.2021.0079
4. Kim, T., Lee, J.S., and Ju, Y.S. (2021). Experimental models for SARS-CoV-2 infection. Mol. Cells 44, 377-383. https://doi.org/10.14348/molcells.2021.0094
5. Lee, E. and Oh, J.E. (2021). Humoral immunity against SARS-CoV-2 and the impact on COVID-19 pathogenesis. Mol. Cells 44, 392-400. https://doi.org/10.14348/molcells.2021.0075
6. Noh, J.Y., Jeong, H.W., and Shin, E.C. (2021). SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern. Signal Transduct. Target. Ther. 6, 203. https://doi.org/10.1038/s41392-021-00623-2
7. Park, S.H. (2021). An impaired inflammatory and innate immune response in COVID-19. Mol. Cells 44, 384-391. https://doi.org/10.14348/molcells.2021.0068
8. Rha, M.S., Kim, A.R., and Shin, E.C. (2021). SARS-CoV-2-specific T cell responses in patients with COVID-19 and unexposed individuals. Immune Netw. 21, e2. https://doi.org/10.4110/in.2021.21.e2
9. Shah, M. and Woo, H.G. (2021). Molecular perspectives of SARS-CoV-2: pathology, immune evasion, and therapeutic interventions. Mol. Cells 44, 408-421. https://doi.org/10.14348/molcells.2021.0026
10. World Health Organization (2021). COVID-19 Weekly Epidemiological Update (43rd Edition) (Geneva: World Health Organization).